Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2026)
Q32 Bio (QTTB) posted quarterly Other Working Capital Changes of -$168000.0 for Q1 2026, down 12.75% year-over-year from -$192553.8 in Q1 2025, and down 7.01% quarter-over-quarter from -$157000.0 in Q4 2025.
Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Q32 Bio's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$168000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 12.75% year-over-year to -$168000.0; the TTM figure through Mar 2026 stood at -$631000.0 (up 65.02% YoY), while the FY2025 annual figure was -$612000.0, up 60.31% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$168000.0, down from -$157000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $6.6 million in Q2 2022, with the low at -$25.7 million in Q4 2023.
- The 5-year median for Other Working Capital Changes is -$507000.0 (2022), against an average of -$1.7 million.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 97.24% in 2022, then slumped 372.73% in 2024.
- Q32 Bio's Other Working Capital Changes stood at -$802000.0 in 2022, then jumped by 84.91% to -$121000.0 in 2023, then tumbled by 372.73% to -$572000.0 in 2024, then soared by 72.55% to -$157000.0 in 2025, then retreated by 7.01% to -$168000.0 in 2026.
- Business Quant data shows QTTB's Other Working Capital Changes at -$168000.0 in Q1 2026, -$157000.0 in Q4 2025, and -$155000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.08 Mn |
| Jun 30, 2026 | -3.08 Mn |
| Jun 30, 2026 | -3.08 Mn |
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Sep 30, 2025 | -1.72 Mn |
| Sep 30, 2025 | -1.72 Mn |
| Sep 30, 2025 | -1.72 Mn |
| Jun 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 343,000.00 |
| Mar 31, 2025 | -763,000.00 |
| Mar 31, 2025 | -763,000.00 |
| Mar 31, 2025 | -763,000.00 |
| Dec 31, 2024 | -908,000.00 |
| Dec 31, 2024 | -908,000.00 |